Retraction

Risedronate and Ergocalciferol Prevent Hip Fracture in Elderly Men with Parkinson Disease

Paper Information

Record ID:
6554
Author(s):
Yoshihiro Sato
Yoshiaki Honda
Jun Iwamoto
Journal:
Neurology ( American Academy of Neurology )
Publication Date:
March 20, 2007
Retraction Date:
July 12, 2016 (9.4 years years ago)
Subjects:
Broad Categories:
Medicine
Institutions:
Country:
🇯🇵 Japan
Article Type:
Research Article
Publisher:
American Academy of Neurology
Open Access:
Yes
DOI:
10.1212/01.wnl.0000257089.50476.92
PubMed ID:
17372126
Retraction PubMed ID:
27402945

Retraction Details

Retraction Reasons:
Nature of Retraction:

Retraction

Retraction Notice:
10.1212/WNL.0000000000003021
Additional Notes:

Y Sato named for misconduct;

Citations (84)

84
Total Citations
22
Post-Retraction
(26.2%)
56
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
12 Within 1 year
8 After 2+ years
1910 Days since retraction (latest)
Paper citing Risedronate sodium therapy for prevention of hip f...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Risedronate and Ergocalciferol Prevent Hip Fractur...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Risedronate and Ergocalciferol Prevent Hip Fractur...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing High prevalence of vitamin D deficiency and reduce...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Risedronate and Ergocalciferol Prevent Hip Fractur...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Homocysteine as a predictive factor for hip fractu...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Abnormal bone and calcium metabolism in immobilize...
Unknown Authors
Unknown Journal
Published: Oct 2021
1910 days after retraction
Paper citing Risedronate sodium therapy for prevention of hip f...
Unknown Authors
Unknown Journal
Published: Jan 2021
1661 days after retraction
Biochemical markers of bone turnover in osteoporosis
Paweł Szulc, Douglas C. Bauer, Richard Eastell
Elsevier eBooks
Published: Nov 2020
9 citations
1577 days after retraction
Paper citing Risedronate and Ergocalciferol Prevent Hip Fractur...
Unknown Authors
Unknown Journal
Published: Oct 2020
1569 days after retraction
An investigation into the impact and implications of published papers from retracted research: systematic search of affected literature
Alison Avenell, Fiona Stewart, Andrew Grey et al. (5 authors)
BMJ Open Open Access
Published: Oct 2019
54 citations
1176 days after retraction
Paper citing Amelioration of osteopenia and hypovitaminosis D b...
Unknown Authors
Unknown Journal
Published: Aug 2019
1144 days after retraction
Paper citing Once-weekly risedronate for prevention of hip frac...
Unknown Authors
Unknown Journal
Published: Sep 2018
808 days after retraction
Paper citing Risedronate and Ergocalciferol Prevent Hip Fractur...
Unknown Authors
Unknown Journal
Published: Aug 2018
758 days after retraction
Paper citing Risedronate and Ergocalciferol Prevent Hip Fractur...
Unknown Authors
Unknown Journal
Published: Sep 2017
429 days after retraction
Does compensatory hyperparathyroidism predispose to ischemic stroke? Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy; An alternative to vitamin D supplementation to prevent fractures in patients with MS; High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease
Unknown Authors
Neurology
Published: Sep 2017
4 citations
422 days after retraction
Bone Health in Parkinson’s Disease
Leyre Riancho‐Zarrabeitia, Manuel Delgado‐Alvarado
Clinical Reviews in Bone and Mineral Metabolism
Published: Jun 2017
4 citations
338 days after retraction
Paper citing Risedronate and Ergocalciferol Prevent Hip Fractur...
Unknown Authors
Unknown Journal
Published: Jun 2017
335 days after retraction
Fragility Fractures and Parkinsonism: Relationship of Fractures with Demography, Severity and Predictors of Adverse Outcomes
S Aithal, Ruford Sequeira, Chris Edwards et al. (4 authors)
Geriatrics Open Access
Published: May 2017
11 citations
316 days after retraction
Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A Clinical Practice Guideline Update From the American College of Physicians
Amir Qaseem, Mary Ann Forciea, Robert McLean et al. (4 authors)
Annals of Internal Medicine Open Access
Published: May 2017
598 citations
301 days after retraction
Paper citing Risedronate and Ergocalciferol Prevent Hip Fractur...
Unknown Authors
Unknown Journal
Published: Jan 2017
181 days after retraction
Paper citing Risedronate and Ergocalciferol Prevent Hip Fractur...
Unknown Authors
Unknown Journal
Published: Jan 2017
181 days after retraction
Osteoporosis: A Hidden Nonmotor Face of Parkinson's Disease
Vinod Metta, Tamara C. Sanchez, Chandrasekhara Padmakumar
International review of neurobiology
Published: Jan 2017
40 citations
173 days after retraction
Paper citing Risedronate and Ergocalciferol Prevent Hip Fractur...
Unknown Authors
Unknown Journal
Published: Nov 2016
120 days after retraction
Paper citing High prevalence of vitamin D deficiency and reduce...
Unknown Authors
Unknown Journal
Published: Nov 2016
112 days after retraction
Paper citing Homocysteine as a predictive factor for hip fractu...
Unknown Authors
Unknown Journal
Published: Oct 2016
111 days after retraction
Paper citing Risedronate and Ergocalciferol Prevent Hip Fractur...
Unknown Authors
Unknown Journal
Published: Oct 2016
81 days after retraction
Risk Factors, Epidemiology and Treatment Strategies for Metabolic Bone Disease in Patients with Neurological Disease
Sophie Binks, Ruth Dobson
Current Osteoporosis Reports
Published: Aug 2016
14 citations
34 days after retraction
Paper citing Sunlight exposure is important for preventing hip ...
Unknown Authors
Unknown Journal
Published: Jun 2016
12 days before retraction
Paper citing Risedronate and Ergocalciferol Prevent Hip Fractur...
Unknown Authors
Unknown Journal
Published: Apr 2016
81 days before retraction
Paper citing Risedronate and Ergocalciferol Prevent Hip Fractur...
Unknown Authors
Unknown Journal
Published: Nov 2015
251 days before retraction
Parkinson's disease: A risk factor for osteoporosis
I. de Chazeron, Bruno Pereira, Isabelle Chéreau‐Boudet et al. (12 authors)
Joint Bone Spine
Published: Oct 2015
46 citations
273 days before retraction
La maladie de Parkinson : un facteur de risque d’ostéoporose
Sandrine Malochet‐Guinamand, Franck Durif, Thierry Thomas
Revue du Rhumatisme
Published: Oct 2015
273 days before retraction
Paper citing Abnormal bone and calcium metabolism in immobilize...
Unknown Authors
Unknown Journal
Published: Sep 2015
311 days before retraction
Paper citing Risedronate and Ergocalciferol Prevent Hip Fractur...
Unknown Authors
Unknown Journal
Published: Mar 2015
474 days before retraction
Paper citing High prevalence of vitamin D deficiency and reduce...
Unknown Authors
Unknown Journal
Published: Mar 2015
476 days before retraction
Paper citing An Open-Label Trial Comparing Alendronate and Alph...
Unknown Authors
Unknown Journal
Published: Nov 2014
619 days before retraction
Paper citing Once-weekly risedronate for prevention of hip frac...
Unknown Authors
Unknown Journal
Published: Jun 2014
772 days before retraction
A review of vitamin D and Parkinson's disease
Amie Peterson
Maturitas
Published: Mar 2014
44 citations
859 days before retraction
Paper citing Risedronate sodium therapy for prevention of hip f...
Unknown Authors
Unknown Journal
Published: Aug 2013
1075 days before retraction
Paper citing Risedronate sodium therapy for prevention of hip f...
Unknown Authors
Unknown Journal
Published: Jul 2013
1107 days before retraction
Ostéoporose et maladie de Parkinson
Thierry Thomas
Revue du Rhumatisme Monographies
Published: Apr 2013
1198 days before retraction
Vitamin D reduces falls and hip fractures in vascular Parkinsonism but not in Parkinson’s disease
Yoshihiro Satō, Jun Iwamaoto, Honda et al. (4 authors)
Therapeutics and Clinical Risk Management Open Access
Published: Apr 2013
12 citations
1198 days before retraction
Musculoskeletal problems in Parkinson’s disease
Young Eun Kim, Beom S. Jeon
Journal of Neural Transmission
Published: Feb 2013
41 citations
1239 days before retraction
Parkinson's disease and osteoporosis
Frederiek van den Bos, A.D. Speelman, M Samson et al. (6 authors)
Age and Ageing Open Access
Published: Nov 2012
119 citations
1344 days before retraction
Paper citing An Open-Label Trial Comparing Alendronate and Alph...
Unknown Authors
Unknown Journal
Published: Oct 2012
1380 days before retraction
Paper citing Risedronate sodium therapy for prevention of hip f...
Unknown Authors
Unknown Journal
Published: May 2012
1505 days before retraction
Parkinson Disease and Metabolic Bone Disorders: A Common Connection That Needs More Attention
Robert M. Levin, Joseph Tucci
Endocrine Practice
Published: May 2012
1 citation
1532 days before retraction
Efficacy of Antiresorptive Agents for Preventing Fractures in Japanese Patients with an Increased Fracture Risk
Jun Iwamoto, Yoshihiro Satō, Tsuyoshi Takeda et al. (4 authors)
Drugs & Aging
Published: Feb 2012
5 citations
1602 days before retraction
Strategy for prevention of hip fractures in patients with Parkinson’s disease
Jun Iwamoto, Yoshihiro Sato, Tsuyoshi Takeda et al. (4 authors)
World Journal of Orthopedics Open Access
Published: Jan 2012
5 citations
1654 days before retraction
Quick Stats
Total Citations: 84
Years Since Retraction: 9.4 years
Open Access: Yes
Last Checked: Never
Related Papers
AAN's First 21st-Century Position Statement on Ethical Cons…
Neurology • 1 citations
An alternative to vitamin D supplementation to prevent frac…
Neurology • 11 citations
Efficacy of Bisphosphonates against Hip Fracture in Elderly…
Journal of Stroke and Cerebrovascular Disease • 10 citations
Hospital Admission and Readmission Among Homeless Patients …
Neurology • 22 citations
High prevalence of vitamin D deficiency and reduced bone ma…
Neurology • 195 citations
Actions
More from this journal Similar subjects View Original Paper View Retraction Notice